Multiple Sclerosis

Title: Air Travel Could Raise Risk for Heartbeat Irregularities
Category: Health News
Created: 3/4/2010 8:10:00 PM
Last Editorial Review: 3/5/2010

Researchers from the Harvard School of Public Health, Walter Reed Army Institute of Research, and a team of collaborators have observed for the first time that the risk of multiple sclerosis (MS) increases by many folds following infection with the Epstein-Barr virus (EBV). This finding implicates EBV as a contributory cause to multiple sclerosis…

http://mnt.to/f/3yy8 Multiple Sclerosis News From Medical News Today

Researchers from the Harvard School of Public Health, Walter Reed Army Institute of Research, and a team of collaborators have observed for the first time that the risk of multiple sclerosis (MS) increases by many folds following infection with the Epstein-Barr virus (EBV). This finding implicates EBV as a contributory cause to multiple sclerosis…

http://mnt.to/f/3yy8 Multiple Sclerosis News From Medical News Today

An innovative scheme piloted in Surrey and Sussex, the first of its kind in the country, has had an overwhelmingly positive impact on the lives of people in the area with multiple sclerosis (MS)…

http://mnt.to/f/3ywR Multiple Sclerosis News From Medical News Today

Title: Oldest Epilepsy Drug Best for Children
Category: Health News
Created: 3/3/2010 6:10:00 PM
Last Editorial Review: 3/4/2010

Living with depression is challenging. Your conversation and sharing is welcome.

Blog - Dealing with depression Blog - Dealing with depression

Results of a phase II clinical trial on the safety and effectiveness of low dose naltrexone (LDN) as a symptom-relief treatment for people with MS have been published in the journal Annals of Neurology. The results of the study suggest that LDN is safe and may have positive effects on the mental quality of life in people with MS; but no effect on a patient’s physical quality of life…

http://mnt.to/f/3yjT Multiple Sclerosis News From Medical News Today

Title: Tularemia
Category: Diseases and Conditions
Created: 2/26/2010 5:26:00 PM
Last Editorial Review: 2/26/2010 5:26:04 PM

A non-pathogenic bacterium is capable of triggering an autoimmune disease similar to multiple sclerosis in the mouse, the model animal which helps to explain how human diseases work…

http://mnt.to/f/3ydq Multiple Sclerosis News From Medical News Today

Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced the publication of data from the 15-year clinical study with Copaxone® (glatiramer acetate injection), which is the longest prospective and continuous evaluation ever conducted in relapsing-remitting multiple sclerosis (RRMS) patients. The data were published in the February issue of the journal Multiple Sclerosis…

http://mnt.to/f/3ydJ Multiple Sclerosis News From Medical News Today